Fulcrum Therapeutics Inc (FULC)
3.22
+0.25
(+8.42%)
USD |
NASDAQ |
Nov 22, 11:55
Fulcrum Therapeutics Shareholders Equity (Quarterly): 257.29M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 257.29M |
| June 30, 2024 | 273.79M |
| March 31, 2024 | 213.59M |
| December 31, 2023 | 235.19M |
| September 30, 2023 | 255.46M |
| June 30, 2023 | 275.43M |
| March 31, 2023 | 296.26M |
| December 31, 2022 | 198.94M |
| September 30, 2022 | 221.41M |
| June 30, 2022 | 160.76M |
| March 31, 2022 | 189.16M |
| December 31, 2021 | 211.54M |
| Date | Value |
|---|---|
| September 30, 2021 | 230.61M |
| June 30, 2021 | 110.89M |
| March 31, 2021 | 127.75M |
| December 31, 2020 | 95.18M |
| September 30, 2020 | 104.98M |
| June 30, 2020 | 122.13M |
| March 31, 2020 | 70.63M |
| December 31, 2019 | 87.15M |
| September 30, 2019 | 102.13M |
| June 30, 2019 | 53.46M |
| March 31, 2019 | 65.45M |
| December 31, 2018 | 76.00M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
70.63M
Minimum
Mar 2020
296.26M
Maximum
Mar 2023
186.91M
Average
205.24M
Median
Shareholders Equity (Quarterly) Benchmarks
| Bioventus Inc | 148.74M |
| Arcturus Therapeutics Holdings Inc | 261.87M |
| Johnson & Johnson | 70.16B |
| Pfizer Inc | 92.29B |
| Tenon Medical Inc | 8.191M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 279.01M |
| Total Liabilities (Quarterly) | 21.72M |